# 🧬 CGT 每日情报 (Daily Brief)
> **日期**: 2026-02-02 | **更新时间**: 09:23 (北京时间)
> **监控范围**: Global (In vivo/FDA) & China (NMPA/Biotech)

---

## 🌍 全球前沿 (FDA / In vivo / MNCs)
- *当前暂无过去 24 小时内的相关重磅全球资讯。*

---

## 🇨🇳 中国动态 (NMPA / Domestic Players)
- `[08:01]` **外周BCMA CAR-T及正常淋巴细胞动力学对多发性骨髓瘤患者疗效的影响** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE41QzNjRDFiUFJUdjVhNUUtcTJPUkJRckRtR2YyTGRGWHNUWWh5QW9EckNld1huRC1vOWlZWVh5SjRoV1dBVjVUd2VIelB1b1ZJRE9YZldWQTZKQ2NHY0FBSC0zZHhtcUJMUEZKZ0pkRnpHQWNJOHlGcFZMOERaQQ?oc=5)
- `[06:07]` **石药集团获得中国首个体内 CAR-T 疗法临床批准**
  <br><small>🇬🇧 *CSPC Wins China’s First Clinical Green Light for In Vivo CAR-T Therapy* [🔗Source](https://news.google.com/rss/articles/CBMivgFBVV95cUxQcXIzeUJ4QWY3dlRWSTVFQkVrRHVWZV90ZEpGNHZuU1ZoeFc4dUxZR1NBMlVaTWd5RURocVJqQm91cWVQcmx0UFlQRmtrdVYxbnItV2ZSeGZMRU9qOHMzN29nSDBYcTg4STdVS2VHUUltdkItVjhvc2JMRGMyMTNaS2NlSy1ieHVrSWE2eEtFVkZ4am9sbHN2VnVtZjc2UU5fUE5DRm9jQjFLTEpPOW5GZEluWGhHQ1BjNTkwSVZ3?oc=5)</small>
- `[15:54]` **产学研融合新标杆：诚意药业-孙毅团队-上海干细胞临床转化研究院，共筑干细胞产业化闭环** [🔗阅读原文](https://news.google.com/rss/articles/CBMi-gFBVV95cUxQWUNYVVdVcXpBaXlzWWVzcUljMDc0QkxIQzRVZ01MYk5fWkh1eGIyeW1ITVA0RDJVQlpqWTVOZTNkSnhiaDJfbEpIM3hHNm56NW9HWkZJQmk3TlNibzV0cS1OSHhJVlVLYU1GOWw1bmdHNGtzSjNCNGFpQW15aHNfN1FnNnpKR3M5TUEzYXN1OURQaWxWUWx6cDA1YjlhTHg0RXdrN2c4SW91SWtwY0ZKRW1Bbmw4WHdTUHM3Z1ZyUFRQdUU2M0VoaG5IUFZHNThIaWtjcnZNbkJnR3N1TG44M1JKcTF0V1dVMG9MejJQY1FXLVh1dHh1dU13?oc=5)
- `[13:51]` **RRMM BCMA CAR-T细胞治疗后淋巴细胞增多的形态学及免疫表型特征研究-MedSci.cn** [🔗阅读原文](https://news.google.com/rss/articles/CBMibkFVX3lxTFBGZTF4dlhMUF9rQXF6cUZSbWw1UmFZSFA4dnRxQWdud3hLdUUwMXpXbUJtR1k1Q1NPcEZQWTA0ek5UX0p3aks2dURMZnYtS2hicllUOGZ2b1kzZllaOUdfeUh1MTFUUHB0c0pBN2hn?oc=5)
